Dutoprol (AstraZeneca Pharmaceuticals LP)
Welcome to the PulseAid listing for the Dutoprol drug offered from AstraZeneca Pharmaceuticals LP. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AstraZeneca Pharmaceuticals LP |
| NON-PROPRIETARY NAME: | metoprolol succinate and hydrochlorothiazide |
| SUBSTANCE NAME: | METOPROLOL SUCCINATE; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-12-30 |
| END MARKETING DATE: | 2017-11-30 |
Dutoprol HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dutoprol from AstraZeneca Pharmaceuticals LP |
| LABELER NAME: | AstraZeneca Pharmaceuticals LP |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50; 12.5(mg/1; mg/1) |
| START MARKETING DATE: | 2011-12-30 |
| END MARKETING DATE: | 2017-11-30 |
| PRODUCT ID: | 0310-1095_81576f3e-10bd-4d55-b42d-9ecf1e1e4914 |
| PRODUCT NDC: | 0310-1095 |
| APPLICATION NUMBER: | NDA021956 |
Other METOPROLOL SUCCINATE; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
